Neuren Pharmaceuticals Quote - NEU

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

13.13

Bid

13.08

Offer

13.19

Volume

725,687

12.88 Day's Range 13.96

8.61 52 Week Range 170.09

Market Cap

1.677B

Previous Close

13.98

Open

13.95

Last Trade

922

13.1

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

709,746

Shares Outstanding

127,695,676

Dividend Yield

PE Ratio

11.80

Earnings Per Share (EPS)

1.11

Revenue

213.25M

Net Profit

142.04M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.neurenpharma.com

Headquarters

Auckland, Nzl

Founded

Neuren Pharmaceuticals Limited is listed in the Pharmaceutical Preparations sector of the Australian Stock Exchange with ticker NEU. The last closing price for Neuren Pharmaceuticals was AUD13.98. Over the last year, Neuren Pharmaceuticals shares have traded in a share price range of AUD 8.61 to AUD 170.09.

Neuren Pharmaceuticals currently has 127,695,676 shares in issue. The market capitalisation of Neuren Pharmaceuticals is AUD1.79 billion. Neuren Pharmaceuticals has a price to earnings ratio (PE ratio) of 11.80.

ACADIA Pharmaceuticals & Neuren Pharmaceuticals Announce Rare Pediatric Disease Designation for Trofinetide for the Treatment...

With No Approved Treatments in Rett Syndrome, FDA Decision Highlights Significant Unmet Need ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) and...

FDA Grants Orphan Drug Designation for Neuren's NNZ-2591 to Treat Angelman, Phelan-McDermid and Pitt Hopkins Syndromes

Neuren Pharmaceuticals (ASX: NEU) today announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation to Neuren’s...

Positive Phase 2 Study Results of Trofinetide in Pediatric Rett Syndrome Published in Neurology, the Medical Journal of the A...

-- Statistically Significant Improvement Indicates Trofinetide’s Potential for Treating Rett Syndrome-- Trofinetide for Rett Syndrome has...

ACADIA Pharmaceuticals & Neuren Pharmaceuticals Announce Exclusive License Agreement for the North American Development & Com...

-ACADIA plans to initiate a Phase 3 study of trofinetide for the treatment of Rett syndrome, a rare neurodevelopmental congenital CNS...

American Stock Exchange to Trade Options on Five New Securities

NEW YORK, April 12 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) will launch trading in options on Thursday, April 13, 2006 on the...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.71	-5.13005780347	13.84	14.22	12.88	372484	13.89202631	DE
4	-0.04	-0.303720577069	13.17	14.5	12.41	421702	13.55597696	DE
12	0.88	7.18367346939	12.25	14.5	8.61	709746	11.52284962	DE
26	-0.37	-2.74074074074	13.5	14.83	8.61	597642	12.12290509	DE
52	-5.83	-30.7489451477	18.96	170.09	8.61	553803	13.67784213	DE
156	9.53	264.722222222	3.6	170.09	3.33	524571	13.35129825	DE
260	11.62	769.536423841	1.51	170.09	0.995	384147	11.41794993	DE

NEU - Frequently Asked Questions (FAQ)

What is the current Neuren Pharmaceuticals share price?

The current share price of Neuren Pharmaceuticals is AUD 13.13

How many Neuren Pharmaceuticals shares are in issue?

Neuren Pharmaceuticals has 127,695,676 shares in issue

What is the market cap of Neuren Pharmaceuticals?

The market capitalisation of Neuren Pharmaceuticals is AUD 1.79B

What is the 1 year trading range for Neuren Pharmaceuticals share price?

Neuren Pharmaceuticals has traded in the range of AUD 8.61 to AUD 170.09 during the past year

What is the PE ratio of Neuren Pharmaceuticals?

The price to earnings ratio of Neuren Pharmaceuticals is 11.8

What is the cash to sales ratio of Neuren Pharmaceuticals?

The cash to sales ratio of Neuren Pharmaceuticals is 7.86

What is the reporting currency for Neuren Pharmaceuticals?

Neuren Pharmaceuticals reports financial results in NZD

What is the latest annual turnover for Neuren Pharmaceuticals?

The latest annual turnover of Neuren Pharmaceuticals is NZD 213.25M

What is the latest annual profit for Neuren Pharmaceuticals?

The latest annual profit of Neuren Pharmaceuticals is NZD 142.04M

What is the registered address of Neuren Pharmaceuticals?

The registered address for Neuren Pharmaceuticals is SUITE 201, 697 BURKE ROAD, CAMBERWELL, VIC 3124, AUCKLAND

What is the Neuren Pharmaceuticals website address?

The website address for Neuren Pharmaceuticals is www.neurenpharma.com

Which industry sector does Neuren Pharmaceuticals operate in?

Neuren Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
OSLOncosil Medical Ltd	AUD 0.92 (30,566.67%)	10.07k
OSLOCOncoSil Medical Ltd	AUD 0.095 (9,400.00%)	9.94k
TALTalius Group Ltd	AUD 0.062 (675.00%)	50k
TM1OTerra Metals Ltd	AUD 0.018 (157.14%)	50k
HTMOHighTech Metals Ltd	AUD 0.02 (81.82%)	12.5k
JLLOJindalee Lithium Ltd	AUD 0.04 (-55.56%)	5k
VMLVital Metals Limited	AUD 0.002 (-33.33%)	6.78M
AXPAXP Energy Limited	AUD 0.001 (-33.33%)	50k
AOKAustralian Oil Company Ltd	AUD 0.002 (-33.33%)	15k
PIMOPinnacle Minerals Ltd	AUD 0.002 (-33.33%)	37.5k
OB1Orbminco Ltd	AUD 0.001 (0.00%)	106.9M
NMGNew Murchison Gold Ltd	AUD 0.019 (8.57%)	99.66M
DTRDateline resources Ltd	AUD 0.091 (-9.00%)	81.46M
VAUVault Minerals Ltd	AUD 0.44 (2.33%)	72.84M
RMLResolution Minerals Ltd	AUD 0.034 (0.00%)	69.05M